Table 1 Baseline subject characteristics (N = 120)
Variable | n (%)a |
|---|---|
Age (years), mean ± SD | 58.8 ± 13.5 |
Women | 43 (35.8) |
Clinical presentation | |
ST-elevation ACS | 23 (19.2) |
Non-ST elevation ACS | 53 (44.2) |
Dilated cardiomyopathy and/or heart failure | 37 (30.8) |
Ventricular arrhythmias | 7 (5.8) |
Electrocardiogram | |
Sinus rhythm | 103 (85.8) |
Atrial fibrillation | 17 (14.2) |
ST elevation ≥ 2 leads or LBBB | 29 (24.2) |
Non-ST elevation | 64 (53.3) |
Comorbidities | |
Hypertension | 62 (51.7) |
Diabetes mellitus | 20 (16.7) |
Dyslipidemia | 40 (33.3) |
Current smoking habit | 42 (35) |
History of atrial fibrillation | 17 (14.2) |
History of stroke/TIA | 7 (5.8) |
Alcohol abuse | 19 (15.8) |
Drug abuse | 12 (10) |
eGFR (mL/min/1.73 m2), mean ± SD | 80 ± 34 |
Treatment at discharge | |
Aspirin | 72 (60) |
Dual antiplatelet therapy | 22 (18.3) |
Oral anticoagulants | 38 (31.7) |
Beta-blockers | 68 (56.7) |
ACEI/ARB | 81 (67.5) |
Statins | 71 (59.2) |